Kezar Historical Balance Sheet

KZR Stock

USD 7.47 0.07 0.95%

Trend analysis of Kezar Life Sciences balance sheet accounts such as Total Stockholder Equity of 129.1 M provides information on Kezar Life's total assets, liabilities, and equity, which is the actual value of Kezar Life Sciences to its prevalent stockholders. By breaking down trends over time using Kezar Life balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Kezar Life Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Kezar Life Sciences is a good buy for the upcoming year.

Kezar Life Inventory

2.09 Million

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kezar Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Kezar Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Kezar Life Sciences at a specified time, usually calculated after every quarter, six months, or one year. Kezar Life Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Kezar Life and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Kezar currently owns. An asset can also be divided into two categories, current and non-current.

Kezar Life Balance Sheet Chart

At this time, Kezar Life's Net Receivables is relatively stable compared to the past year. As of 11/29/2024, Common Stock Total Equity is likely to grow to about 82.1 K, while Other Current Liabilities is likely to drop slightly above 2.3 M.

Total Assets Other Current Liab Total Current Liabilities Other Liab Other Assets Total Current Assets

Add Fundamental

Total Assets

Total assets refers to the total amount of Kezar Life assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Kezar Life Sciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Kezar Life balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Kezar Life Sciences are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Current Assets

The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.

Most accounts from Kezar Life's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Kezar Life Sciences current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kezar Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

	2021	2022	2023	2024 (projected)
Other Current Liabilities	3.8M	3.4M	3.5M	2.3M
Total Assets	217.9M	299.6M	221.2M	159.6M

Other Current Liab Total Assets

Kezar Life balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Preferred Stock Total Equity	Total Current Assets
Total Assets		0.91	0.81	0.99	0.87	0.91	0.93	-0.39	-0.85	0.6	0.74	0.92	0.47	0.82	1.0	0.65	0.91	0.92	-0.41	0.91	0.91	0.91	-0.18	0.97	0.81	1.0
Other Current Liab	0.91		0.73	0.9	0.82	0.85	0.74	-0.52	-0.77	0.57	0.77	0.76	0.47	0.73	0.92	0.49	0.84	0.81	-0.39	0.83	0.73	0.79	-0.19	0.81	0.78	0.92
Total Current Liabilities	0.81	0.73		0.79	0.84	0.97	0.79	-0.16	-0.99	0.94	0.56	0.86	0.88	0.95	0.8	0.89	0.96	0.84	-0.38	0.98	0.74	0.96	-0.16	0.84	0.64	0.8
Total Stockholder Equity	0.99	0.9	0.79		0.9	0.91	0.94	-0.3	-0.83	0.58	0.65	0.92	0.44	0.77	0.99	0.61	0.9	0.9	-0.55	0.89	0.89	0.89	-0.34	0.96	0.78	0.99
Other Liab	0.87	0.82	0.84	0.9		0.9	0.88	-0.29	-0.81	0.65	0.6	0.87	0.57	0.8	0.87	0.58	0.88	0.74	-0.59	0.88	0.67	0.84	-0.4	0.85	0.87	0.87
Net Tangible Assets	0.91	0.85	0.97	0.91	0.9		0.87	-0.22	-0.97	0.85	0.62	0.9	0.76	0.92	0.91	0.82	0.99	0.89	-0.49	1.0	0.82	0.98	-0.27	0.91	0.7	0.91
Property Plant And Equipment Net	0.93	0.74	0.79	0.94	0.88	0.87		-0.16	-0.8	0.56	0.54	0.96	0.44	0.8	0.92	0.69	0.85	0.84	-0.5	0.86	0.88	0.87	-0.29	0.97	0.79	0.93
Net Debt	-0.39	-0.52	-0.16	-0.3	-0.29	-0.22	-0.16		0.18	-0.05	-0.89	-0.14	-0.01	-0.27	-0.41	0.08	-0.24	-0.25	-0.38	-0.22	-0.14	-0.21	-0.47	-0.22	-0.57	-0.4
Retained Earnings	-0.85	-0.77	-0.99	-0.83	-0.81	-0.97	-0.8	0.18		-0.93	-0.59	-0.88	-0.85	-0.94	-0.85	-0.89	-0.98	-0.9	0.36	-0.99	-0.8	-0.98	0.13	-0.87	-0.63	-0.85
Accounts Payable	0.6	0.57	0.94	0.58	0.65	0.85	0.56	-0.05	-0.93		0.42	0.69	0.98	0.87	0.6	0.89	0.86	0.72	-0.25	0.87	0.58	0.85	-0.05	0.63	0.44	0.6
Cash	0.74	0.77	0.56	0.65	0.6	0.62	0.54	-0.89	-0.59	0.42		0.53	0.33	0.63	0.75	0.33	0.64	0.63	0.13	0.62	0.52	0.63	0.31	0.61	0.75	0.74
Non Current Assets Total	0.92	0.76	0.86	0.92	0.87	0.9	0.96	-0.14	-0.88	0.69	0.53		0.6	0.87	0.91	0.77	0.89	0.9	-0.46	0.9	0.88	0.9	-0.21	0.98	0.8	0.91
Non Currrent Assets Other	0.47	0.47	0.88	0.44	0.57	0.76	0.44	-0.01	-0.85	0.98	0.33	0.6		0.83	0.47	0.86	0.75	0.58	-0.17	0.78	0.43	0.74	0.01	0.52	0.37	0.47
Other Assets	0.82	0.73	0.95	0.77	0.8	0.92	0.8	-0.27	-0.94	0.87	0.63	0.87	0.83		0.81	0.91	0.91	0.79	-0.18	0.93	0.76	0.91	0.05	0.84	0.71	0.81
Cash And Short Term Investments	1.0	0.92	0.8	0.99	0.87	0.91	0.92	-0.41	-0.85	0.6	0.75	0.91	0.47	0.81		0.64	0.91	0.92	-0.41	0.9	0.9	0.91	-0.18	0.96	0.81	1.0
Net Receivables	0.65	0.49	0.89	0.61	0.58	0.82	0.69	0.08	-0.89	0.89	0.33	0.77	0.86	0.91	0.64		0.82	0.74	-0.16	0.85	0.75	0.85	0.04	0.74	0.41	0.64
Common Stock Total Equity	0.91	0.84	0.96	0.9	0.88	0.99	0.85	-0.24	-0.98	0.86	0.64	0.89	0.75	0.91	0.91	0.82		0.92	-0.45	0.99	0.84	0.99	-0.23	0.9	0.69	0.91
Common Stock Shares Outstanding	0.92	0.81	0.84	0.9	0.74	0.89	0.84	-0.25	-0.9	0.72	0.63	0.9	0.58	0.79	0.92	0.74	0.92		-0.35	0.9	0.93	0.93	-0.1	0.92	0.66	0.92
Non Current Liabilities Total	-0.41	-0.39	-0.38	-0.55	-0.59	-0.49	-0.5	-0.38	0.36	-0.25	0.13	-0.46	-0.17	-0.18	-0.41	-0.16	-0.45	-0.35		-0.44	-0.32	-0.41	0.96	-0.44	-0.24	-0.41
Capital Surpluse	0.91	0.83	0.98	0.89	0.88	1.0	0.86	-0.22	-0.99	0.87	0.62	0.9	0.78	0.93	0.9	0.85	0.99	0.9	-0.44		0.83	0.99	-0.22	0.9	0.68	0.9
Other Current Assets	0.91	0.73	0.74	0.89	0.67	0.82	0.88	-0.14	-0.8	0.58	0.52	0.88	0.43	0.76	0.9	0.75	0.84	0.93	-0.32	0.83		0.87	-0.1	0.92	0.59	0.91
Other Stockholder Equity	0.91	0.79	0.96	0.89	0.84	0.98	0.87	-0.21	-0.98	0.85	0.63	0.9	0.74	0.91	0.91	0.85	0.99	0.93	-0.41	0.99	0.87		-0.18	0.92	0.66	0.91
Total Liab	-0.18	-0.19	-0.16	-0.34	-0.4	-0.27	-0.29	-0.47	0.13	-0.05	0.31	-0.21	0.01	0.05	-0.18	0.04	-0.23	-0.1	0.96	-0.22	-0.1	-0.18		-0.2	-0.03	-0.18
Property Plant And Equipment Gross	0.97	0.81	0.84	0.96	0.85	0.91	0.97	-0.22	-0.87	0.63	0.61	0.98	0.52	0.84	0.96	0.74	0.9	0.92	-0.44	0.9	0.92	0.92	-0.2		0.76	0.96
Preferred Stock Total Equity	0.81	0.78	0.64	0.78	0.87	0.7	0.79	-0.57	-0.63	0.44	0.75	0.8	0.37	0.71	0.81	0.41	0.69	0.66	-0.24	0.68	0.59	0.66	-0.03	0.76		0.81
Total Current Assets	1.0	0.92	0.8	0.99	0.87	0.91	0.93	-0.4	-0.85	0.6	0.74	0.91	0.47	0.81	1.0	0.64	0.91	0.92	-0.41	0.9	0.91	0.91	-0.18	0.96	0.81

Click cells to compare fundamentals

Kezar Life Account Relationship Matchups

Kezar Life balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	89.5M	151.8M	217.9M	299.6M	221.2M	159.6M
Other Current Liab	62K	2M	3.8M	3.4M	3.5M	2.3M
Total Current Liabilities	6.0M	6.4M	8.2M	11.0M	17.7M	18.6M
Total Stockholder Equity	78.0M	141.0M	196.9M	269.9M	187.6M	129.1M
Net Tangible Assets	78.0M	141.0M	196.9M	269.9M	310.4M	325.9M
Property Plant And Equipment Net	8.1M	6.7M	6.0M	13.2M	8.7M	6.8M
Net Debt	(8.6M)	(15.8M)	(48.8M)	(19.2M)	(16.6M)	(17.4M)
Retained Earnings	(84.3M)	(126.0M)	(180.7M)	(248.9M)	(350.8M)	(333.2M)
Accounts Payable	823K	2.4M	2.0M	2.5M	8.3M	8.7M
Cash	15.0M	21.2M	62.9M	40.5M	35.5M	35.7M
Non Current Assets Total	8.4M	7.0M	6.3M	13.8M	14.3M	7.9M
Cash And Short Term Investments	78.2M	140.4M	208.4M	276.6M	201.4M	147.6M
Net Receivables	642K	766K	70K	2.3M	2.6M	2.8M
Common Stock Shares Outstanding	19.1M	44.0M	52.8M	67.4M	72.6M	40.2M
Liabilities And Stockholders Equity	89.5M	151.8M	217.9M	299.6M	221.2M	159.6M
Non Current Liabilities Total	5.5M	4.4M	12.8M	18.7M	15.9M	16.7M
Capital Surpluse	162.5M	267.1M	377.8M	519.6M	597.6M	627.4M
Other Current Assets	1.0M	4.4M	3.3M	9.2M	5.6M	3.4M
Other Stockholder Equity	162.5M	267.1M	377.8M	519.6M	538.4M	565.3M
Total Liab	11.5M	10.9M	21.1M	29.7M	33.7M	22.1M
Property Plant And Equipment Gross	8.1M	6.7M	9.6M	17.8M	14.1M	8.7M
Total Current Assets	81.1M	144.8M	211.7M	285.7M	207.0M	151.6M
Accumulated Other Comprehensive Income	(196K)	(137K)	(291K)	(923K)	(130K)	(136.5K)
Property Plant Equipment	8.1M	3.4M	3.3M	3.4M	3.9M	4.0M
Net Invested Capital	78.0M	141.0M	206.5M	279.7M	197.6M	154.9M
Net Working Capital	75.1M	138.4M	203.4M	274.7M	189.2M	163.1M
Retained Earnings Total Equity	(84.3M)	(126.0M)	(180.7M)	(248.9M)	(224.0M)	(212.8M)
Short Term Investments	63.3M	119.2M	145.5M	236.1M	165.9M	149.1M

Pair Trading with Kezar Life

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Kezar Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kezar Life will appreciate offsetting losses from the drop in the long position's value.

Moving together with Kezar Stock

0.76

EWTX

Edgewise Therapeutics

Pair Corr

Moving against Kezar Stock

0.57	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.51	TAK	Takeda Pharmaceutical	Pair Corr
0.51	LTRN	Lantern Pharma	Pair Corr
0.5	HLN	Haleon plc	Pair Corr
0.46	ELAN	Elanco Animal Health	Pair Corr

The ability to find closely correlated positions to Kezar Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Kezar Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Kezar Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Kezar Life Sciences to buy it.

The correlation of Kezar Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Kezar Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Kezar Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Kezar Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Kezar Stock Analysis

When running Kezar Life's price analysis, check to measure Kezar Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kezar Life is operating at the current time. Most of Kezar Life's value examination focuses on studying past and present price action to predict the probability of Kezar Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kezar Life's price. Additionally, you may evaluate how the addition of Kezar Life to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Kezar Historical Balance Sheet

Kezar Life Inventory

2.09 Million

About Kezar Balance Sheet Analysis

Kezar Life Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Current Assets

Kezar Life balance sheet Correlations

Kezar Life Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Kezar Life balance sheet Accounts

Pair Trading with Kezar Life

Moving together with Kezar Stock

Moving against Kezar Stock

Additional Tools for Kezar Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Capital Surpluse	+ 1.0	Net Tangible Assets
Total Current Assets	+ 1.0	Cash And Short Term Investments
Total Stockholder Equity	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Total Stockholder Equity

Capital Surpluse	- 0.99	Retained Earnings
Retained Earnings	- 0.99	Total Current Liabilities
Other Stockholder Equity	- 0.98	Retained Earnings
Common Stock Total Equity	- 0.98	Retained Earnings
Retained Earnings	- 0.97	Net Tangible Assets
Other Assets	- 0.94	Retained Earnings